Trial
NCT00176644
Phase II Trial of Transdermal Estradiol for Hormone Refractory Prostate Cancer
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
University of Medicine and Dentistry of New Jersey
Collaborators
National Cancer Institute (NCI)
Condition
Prostate Cancer
Intervention
Transdermal Estradiol
Why stopped
Treatment ineffective
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-09-13